Advertisementspot_img
Saturday, June 22, 2024

Delivering Stories of Progress

Advertisementspot_img

TAG

IgG4-related disease

Zenas BioPharma Earmarks $118M to Fund Immunotherapy Project

Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immune-based therapies, today announced proceeds of $118...

Latest news